ARCHIVES

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

Toxicology Program Board To Review Nine Substances.

January 14, 2000

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

Industry Groups Lobby for Lower Standards for FDA Approval

November 18, 2011

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

McKay Retires As Fox Chase Executive, Is Succeeded By Donald Leedy As VP.

June 2, 2000